United States · 
What does Kaiser Permanente Ventures invest in?
Kaiser Permanente Ventures invests most often at Series B and Series C (53% of the rounds on record), in sectors such as Connected Health, Tech-enabled Health and Health-tech.
Kaiser Permanente Ventures highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series C: 53% of its rounds
- 03
Sole investor in 2 rounds, median $30M
- 04
11 exits from the portfolio
What they do
Kaiser Permanente Ventures makes investments in promising healthcare companies targeting areas of real need.From their own website
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Connected HealthTech-enabled HealthHealth-tech
- Based in
- Oakland, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first59 appearances
- 2026
1 round
- May
- 2025
3 rounds
- Sept
- Jun
- May
- 2024
1 round
- Sept
- 2023
2 rounds
- Jun
- Jan
- 2019
6 rounds
- Sept
- Aug
- Jul
- Jul
- Jun
- Jun
- 2016
1 round
- Sept
- 2015
3 rounds
- Apr
- Jan
- Jan
- 2014
5 rounds
- Dec
- Sept
- Apr
- Apr
- Jan
- 2013
6 rounds
- Nov
- Jun
- Apr
- Apr
- Apr
- Mar
- 2012
9 rounds
- Sept
- Jul
- Jun
- Jun
- Jun
- Mar
- Jan
- Jan
- Jan
- 2011
1 round
- Sept
- 2010
6 rounds
- Sept
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
CLCynthia Lee Vanderlinde-KopperVice President & Managing DirectoriForm ADV
We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$193Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- National Venture Development
- SEC number
- CRD 162019
What they claim to have backed
From their own portfolio page (on their website)
35 of 48 we have independently watched raise
AbridgeAgiletherapeuticsArineAstutemedicalBighealthChronotheraClariumhealthEverytableFreenomeGenomemedicalGynesonicsHeadspaceHealthcatalystIngeniousmedIntelycareKatefarmsKitcheckMetricstreamNexthealthtechnologiesNuvoloOmadahealthOrdrOssovrProtenusRockhealthStartuphealthSurecoTrivascularUsrenalcareValeritasValidicVapothermVidyoWidercircleXanitosCollectivemedicaltechDexcarehealthFlexeraGetgarnerHometeamhealthIrhythmtechJoingroupsLeitersMind24-7NeoseqltdNordicwiProteusTreatmyocd
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed11 in all
AtheroMedBought by Volcano Corporation$117MMay 2014
Oxford ImmunotecListed$64MNov 2013
AccumetricsBought by ITCUndisclosedAug 2013
Zonare Medical SystemsBought by Mindray Medical International$105MJun 2013
BaxanoBought by TranS1UndisclosedMar 2013
HemosphereBought by CryoLife$22MMay 2012
Calypso MedicalBought by Varian Medical SystemsUndisclosedSept 2011
CHF SolutionsBought by GambroUndisclosedJan 2010
NeoGuide SystemsBought by Intuitive SurgicalUndisclosedJun 2009
Bacchus VascularBought by CovidienUndisclosedMar 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.